Name: INNATE PHARMA SA (IPH) Stock
Brand: INNATE PHARMA SA
Rating: 3 (3 reviews)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

Show Percentage Diff	TTM (2025-6-30)	2024 (2024-12-31)	2023 (2023-12-31)	2022 (2022-12-31)	2021 (2021-12-31)
Revenue	6.00M	12.62M	51.90M	49.58M	12.11M
Gross Premiums Earned	null	null	null	null	null
Loss Claims	null	null	null	null	null
Deferred Policy Acquisition Expense	null	null	null	null	null
Net Interest Income	null	null	null	null	null
Non Interest Income	null	null	null	null	null
Loan Loss Provision	null	null	null	null	null
Net Interest Income after Provision	null	null	null	null	null
Non Interest Expense	null	null	null	null	null
Minority Interest Expense	null	null	null	null	null
Cost Of Goods	3.03M	3.06M	2.85M	3.58M	3.06M
Gross Profit	2.97M	9.57M	49.05M	46.00M	9.05M
Operating Expenses	53.66M	61.14M	61.72M	62.42M	56.87M
Research and Development	37.73M	45.05M	49.44M	45.46M	41.21M
Selling, General, and Administrative Expenses	18.59M	18.32M	16.69M	20.24M	23.35M
Operating Income	-50.69M	-51.58M	-12.67M	-16.43M	-47.83M
Interest Income/Expense	3.66M	121.00K	3.45M	1.09M	1.26M
Other Income/Expense	977.00K	1.98M	1.65M	-1.63M	1.08M
Non Recurring Items	null	0	0	-41.00M	null
Income Before Taxes	-46.05M	-49.47M	-7.57M	-57.97M	-45.48M
Income Tax	0	0	0	0	0
Net Income	-46.05M	-49.47M	-7.57M	-58.10M	-52.81M
EBITDA	-49.13M	-49.58M	-7.58M	28.98M	-43.23M

Per Share Data
EPS Diluted Total Ops	-0.5497000000000001	-0.6104	-0.0941	-0.7279	-0.66
Non GAAP EPS	null	null	null	null	null

Statistics
Gross Profit Margin	49.52%	75.79%	94.50%	92.78%	74.69%
Profit Margin	-767.52%	-391.94%	-14.59%	-117.19%	-436.01%
Operating Profit Margin	-844.82%	-408.61%	-24.41%	-33.13%	-394.86%

All data in EUR

INNATE PHARMA SA (IPH.PA) Stock Income Statement

Charts